Gene · 5745
NIH grants1,470
NIH grants whose papers are about the gene, through NIH's grant-paper links.
61 to 80 of 1,470
Download this page as JSON| Grant | Title | PTH1R papers | Newest fiscal year |
|---|---|---|---|
| T32HL129982 | The Genetic Epidemiology of Heart, Lung, and Blood Traits Training Grant (GenHLB) | 2 | 2025 |
| T32NS045549 | Interdisciplinary Training Program in Pain Research | 2 | 2025 |
| U54GM104940 | Louisiana Clinical and Translational Science Center | 2 | 2025 |
| ZIADE000746 | Craniofacial Anomalies and Regeneration | 2 | 2025 |
| ZIADK043006 | Hyperparathyroidism -- Etiology, Diagnosis and Treatment | 2 | 2025 |
| ZICMH002963 | Systems Neuroscience Imaging Resource | 2 | 2025 |
| DP2GM149548 | Post-translational modification proteomics in 4D: Chemoenzymatic tools to map the dynamic spatial organization of eukaryotic signaling pathways | 1 | 2025 |
| F31DK136222 | The role of cell surface glycosaminoglycans (GAGs) in PTHrP bias signaling | 1 | 2025 |
| I01BX001478 | Harnessing the anabolic potential of Wnt signaling to improve bone health | 1 | 2025 |
| I01BX005851 | BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism | 1 | 2025 |
| IK6BX004835 | BLRD Research Career Scientist Award Application | 1 | 2025 |
| K01DK129417 | Glucagon and insulin act cooperatively in the regulation of prandial hepatic glycogen metabolism | 1 | 2025 |
| K01DK132461 | Targeting alpha-cell GPCRs to stimulate glucagon and counter hypoglycemia | 1 | 2025 |
| K12HD000850 | Pediatric Scientist Development Program | 1 | 2025 |
| K12HD052896 | Child Health Research Career Development Award (CHRCDA) Program (K12) | 1 | 2025 |
| P01AG066603 | Skeleton and Joint Degeneration with Aging | 1 | 2025 |
| P01CA013106 | Targeting Transcription and Splicing in Cancer | 1 | 2025 |
| P01CA163222 | Targetable epigenetic and transcriptional mechanisms in melanoma thatshape the microenvironment | 1 | 2025 |
| P01CA206978 | Comprehensive dissection of the CLL genome & phenome to improve patient outcomes | 1 | 2025 |
| P01DA009158 | Endocannabinoid Active Sites as Therapeutic Targets | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5745/grants?page=4